Results 61 to 70 of about 1,151 (123)

Insufficient evidence for an association between iatrogenic Alzheimer's disease and cadaveric pituitary‐derived growth hormone

open access: yesAlzheimer's &Dementia, Volume 20, Issue 10, Page 7399-7402, October 2024.
Abstract A Nature Medicine paper published in January 2024 describes eight cases of iatrogenic Alzheimer's disease in individuals who received cadaveric pituitary‐derived human growth hormone. The paper's conclusions argue for the transmissibility of Alzheimer's disease, which, if true, would create a significant public health crisis.
Avi Nath   +4 more
wiley   +1 more source

Diagnosis and Management of Cerebral Amyloid Angiopathy:A Scientific Statement from the International CAA Association and the World Stroke Organization [PDF]

open access: yes
Cerebral amyloid angiopathy (CAA) is a well-recognized and challenging disease for neurologists and other clinicians caring for the rapidly aging worldwide population. CAA is a major cause of spontaneous lobar intracerebral hemorrhage (ICH), and can also
Al-Shahi Salman, Rustam   +17 more
core   +1 more source

Altering Brain Amyloidosis by Intra-Lingual and Extra-Nasal Exposure of Aβ Aggregates [PDF]

open access: yes, 2022
Extensive experimental and human-derived evidence suggest that misfolded Aβ particles spread similarly to infectious prions. Moreover, peripheral administration of Aβ seeds accelerates brain amyloidosis in both susceptible experimental animals and humans.
Bravo-Alegria, Javiera   +6 more
core   +1 more source

Cerebral amyloid angiopathy decades after red blood cell transfusions:a report of two cases from a prospective cohort [PDF]

open access: yes
Background and purpose: Patients who underwent red blood cell (RBC) transfusion from donors who later developed multiple spontaneous intracerebral hemorrhages (ICHs) have recently been identified to have increased risk of ICH themselves.
Kaushik, K.   +2 more
core   +2 more sources

Alzheimer's disease neuropathological change three decades after iatrogenic amyloid-β transmission [PDF]

open access: yes, 2021
Banerjee, G   +11 more
core   +1 more source

Recent advances in understanding mammalian prion structure [PDF]

open access: yes, 2019
Prions are lethal pathogens, which cause fatal neurodegenerative diseases in mammals. They are unique infectious agents and are composed of self-propagating multi-chain assemblies of misfolded host-encoded prion protein (PrP).
Terry, Cassandra   +1 more
core   +3 more sources

Pathology of neurodegenerative disease for the general neurologist [PDF]

open access: yes, 2023
Neurodegeneration refers to progressive dysfunction or loss of selectively vulnerable neurones from brain and spinal cord regions. Despite important advances in fluid and imaging biomarkers, the definitive diagnosis of most neurodegenerative diseases ...
Bezerra Parmera, Jacy   +8 more
core  

Evidence of amyloid-β cerebral amyloid angiopathy transmission through neurosurgery [PDF]

open access: yes, 2018
Amyloid-β (Aβ) is a peptide deposited in the brain parenchyma in Alzheimer’s disease and in cerebral blood vessels, causing cerebral amyloid angiopathy (CAA).
Barbosa, R   +8 more
core   +1 more source

The role of prion-like mechanisms in neurodegenerative diseases [PDF]

open access: yes, 2020
The prototype of transmissible neurodegenerative proteinopathies is prion disease, characterised by aggregation of abnormally folded conformers of the native prion protein.
Brandner, S, Jaunmuktane, Z
core  

Poster Sessions

open access: yes
HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Home - About - Disclaimer - Privacy